Federated Hermes, Inc. Immuneering Corp Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Immuneering Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,954 shares of IMRX stock, worth $6,761. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,954
Previous 3,838
3.02%
Holding current value
$6,761
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMRX
# of Institutions
37Shares Held
4.78MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.81 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0808KShares$1.38 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD659KShares$1.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$912,0520.0% of portfolio
-
Morgan Stanley New York, NY467KShares$798,9560.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $45.1M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...